. Responsiveness of insulin-induced cardiac sympathetic nerve activation associates with blood pressure regulation in diabetics. Am J Physiol Endocrinol Metab 284: E1022-E1026, 2003. First published February 4, 2003 10.1152/ajpendo.00169.2002To quantitatively evaluate the effect of insulin on cardiac sympathetic nerve activity (SNA) and analyze clinical factors associated with insulin sensitivity for the regulation of SNA in diabetics, 29 Japanese type 2 diabetics without neuropathy were recruited. A 2-h control study and a 2-h hyperinsulinemic euglycemic glucose clamp study were performed. From the power spectral analysis of R-R intervals on ECG during both studies, two major components, the low-frequency (LF) and the highfrequency component (HF), were obtained. Then %LF was calculated as LF/(LF ϩHF), and the ratio of the average %LF during the last 30 min of the clamp or the control to the average %LF for the entire time for clamp or control (R-%LF) was used as a marker of changes in SNA. R-%LF was significantly higher during the clamp than in the control (1.07 Ϯ 0.04 vs. 1.03 Ϯ 0.03, P Ͻ 0.05). High responders (individual R-%LF during clamp Ն mean ϩ 2SD in control) showed a higher basal mean blood pressure (BP) before the clamp (89 Ϯ 3 vs. 82 Ϯ 2, P Ͻ 0.03) but not a higher glucose infusion rate (GIR) compared with low responders (Ͻmean ϩ 2SD). Furthermore, R-%LF showed a positive correlation with basal mean BP (P Ͻ 0.02) but not with GIR. These data demonstrate that an acute insulin load stimulates cardiac SNA, and insulin sensitivity in the regulation of SNA may be associated with BP regulation independently of peripheral insulin sensitivity. insulin action; type 2 diabetes; blood pressure; power spectral analysis INFUSION OF INSULIN during hyperinsulinemic euglycemic glucose clamp studies can enhance sympathetic nerve activity (SNA), as detected by monitoring muscle microelectrodes, but this phenomenon is not observed when glucose or fructose is infused without insulin, suggesting an insulin-specific effect on SNA (20). Although the mechanism of this insulin-induced increase in SNA remains unclear, insulin receptors are expressed in the hypothalamus (7, 11), and direct intraventricular infusion of insulin increases SNA in rats (12). Thus it has been hypothesized that insulin may physiologically enhance SNA, at least partly, via hypothalamic regulation (16). Previous studies have shown that the action of insulin on SNA, as monitored by plasma catecholamine levels or muscle SNA, is not correlated with the glucose infusion rate (GIR), a marker of insulin sensitivity for peripheral glucose uptake during hyperinsulinemic euglycemic glucose clamp studies (14,19). These results suggest that compensatory hyperinsulinemia secondary to peripheral insulin resistance may decrease the GIR and enhance SNA, which in turn may be a possible cause of hypertension through an increment of cardiovascular SNA (16). However, there was no increase of plasma catecholamines during euglycemic hyperinsulinemic clamping, according to...